Generex is an excellent company
Post# of 36537
(Total Views: 345)
Posted On: 08/21/2019 4:29:56 PM
In my opinion generex is an excellent company due to the following reasons:
•Plans for NuGenerex Immuno-Oncology Spinout through a Targeted Acquisition of a Public Company and Planned Merger with Kiromic. According to Generex CEO “Generex is in final negotiations to retain the controlling interest of the outstanding shares of the acquisition target and expects to complete the contracts and file a super 8K in the coming weeks.” – PR Aug. 16, 2019.
•The Uplist to NASDAQ - In the coming weeks we should have news (Uplist can happen anytime!) - With the entry into Nasdaq interest in the company will increase greatly. The media and analysts will pay more attention, the big investors and funds will come in, etc.
•The dividend that will be given to generex investors at the end of October The number of Shares will only increase more or less 15%). According to GENEREX CEO “Generex is able to reward our shareholders with a 1:1 dividend”.
•Financing and the acquisition of new companies after joining NASDAQ. According to Generex CEO “We are doing the necessary work to evaluate the potential of acquiring up to 13 hospitals, which includes rural hospitals designated as federal Critical Access Hospitals (CAHs) that provide payments and incentives under CMS. We are also very active with negotiations to acquire the direct-to-patient pharmacy business that we have audited over the last year. Now that we have completed the audit, we plan to move forward with this acquisition once we are Nasdaq listed..” PR Aug. 19, 2019.
That's why I believe Genetex is a Strong Strong BUY. The next few days / weeks / months promise to be very exciting!
•Plans for NuGenerex Immuno-Oncology Spinout through a Targeted Acquisition of a Public Company and Planned Merger with Kiromic. According to Generex CEO “Generex is in final negotiations to retain the controlling interest of the outstanding shares of the acquisition target and expects to complete the contracts and file a super 8K in the coming weeks.” – PR Aug. 16, 2019.
•The Uplist to NASDAQ - In the coming weeks we should have news (Uplist can happen anytime!) - With the entry into Nasdaq interest in the company will increase greatly. The media and analysts will pay more attention, the big investors and funds will come in, etc.
•The dividend that will be given to generex investors at the end of October The number of Shares will only increase more or less 15%). According to GENEREX CEO “Generex is able to reward our shareholders with a 1:1 dividend”.
•Financing and the acquisition of new companies after joining NASDAQ. According to Generex CEO “We are doing the necessary work to evaluate the potential of acquiring up to 13 hospitals, which includes rural hospitals designated as federal Critical Access Hospitals (CAHs) that provide payments and incentives under CMS. We are also very active with negotiations to acquire the direct-to-patient pharmacy business that we have audited over the last year. Now that we have completed the audit, we plan to move forward with this acquisition once we are Nasdaq listed..” PR Aug. 19, 2019.
That's why I believe Genetex is a Strong Strong BUY. The next few days / weeks / months promise to be very exciting!
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼